BiPI-G0:
Compound 4 (0.1 g, 57.8 μmol) was dissolved in chloroform (15 mL) and then trifluoroacetic acid (5 mL) was added. The resulting mixture was stirred at room temperature overnight. The solvent was removed by rotary evaporation and the residue was washed by dichloromethane (10 mL × 3). BiPI-G0 (82 mg, 95 %) was obtained as a red solid. MS (MALDI-TOF): calcd. for C 96 H 68 N 2 O 16 m/z 1505.46, found m/z 1505.73. Due to aggregation of the dye molecule at high concentration needed, 1 H and 13 C NMR spectra could not be obtained. Scheme S1. Synthesis of the BiPI dendrimers. 
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BiPI-G1:
Trifluoroacetic acid (1 mL) as added to a solution of compound 6 (36 mg, 11.6 μmol) in chloroform (4 mL) and the resulting mixture was stirred at room temperature overnight. The solvent was removed by rotary evaporation. The residue was dissolved in methanol (10 mL) and precipitated out after diethyl ether (100 mL) was added. BiPI-G1 (9 mg, 32 %) was obtained as a red solid after filtration. 1 
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BiPI-G2:
Compound 8 (43 mg, 6 μmol) was dissolved in chloroform (4 mL) and then trifluoroacetic acid (1 mL) was added. The resulting mixture was stirred at room temperature overnight. The solvent was removed by rotary evaporation. The residue was dissolved in methanol (4 mL) and precipitate by adding diethyl ether (50 mL). BiPI-G2 (7 mg, 23 %) was obtained as a red solid after filtration. 1 Photophysical Study of BiPI-G0, BiPI-G1 and BiPI-G2 Figure S1 . The concentration-dependent absorption and emission (λ ex = 530 nm) spectra of (a) BiPI-G0, (b) BiPI-G1 and (c) BiPI-G2 in water.
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Supporting Information Figure S2 . The temperature-dependent emission spectra (λ ex = 530 nm) of (a) BiPI-G0, (b) BiPI-G1 and (c) BiPI-G2 in water at a concentration of 10 μM.
Cytotoxicity
The cell viability assay was performed by using a mouse malignant astrocytoma cell line, wild type delayed brain tumor (WT-DBT). WT-DBT cells were cultured in DMEM containing 10% fetal bovine serum, 4 mM glutamine, 100 units/mL penicillin and 100 µg/mL streptomycin. WT-DBT cells were seeded in 24-well plates at density of ~7×10 4 cells/mL for 24 h in a water-jacketed incubator (37 °C, 5% CO 2 ). Cells were then treated with indicated concentrations of BiPI-G0, BiPI-G1 and BiPI-G2 for 24 h (0 µM, 1 µM, 5 µM to 10 µM). After 24 h incubation, the cells from each group were harvested by trypsinization using a 0.05% trypsin-EDTA solution. Cell toxicity was assessed by a Hemocytometerbased trypan blue dye exclusion method 4 . Indocyanine green (ICG) (Sigma-Aldrich) was used as the negative control and Doxorubicin Hydrochloride (Fisher Scientific) was used as the positive control. Figure S3 . Cytotoxicity study of BiPI-G0, BiPI-G1 and BiPI-G2. To evaluate the cytotoxicity of BiPI-G0, BiPI-G1 and BiPI-G2, WT-DBT cells were incubated with 0, 1, 5, 10 µM of these dendrimers for 24 h. Cell toxicity was measured using the Hemocytometer-based trypan blue dye exclusion method. Indocyanine gree (ICG), the only clinically approved near infrared fluorescent dye, was used as the negative control. Doxorubicin, a commonly used chemotherapy drug, served as the positive control. Each data point represents the mean ± SD based on triplicate samples.
Cell fluorescent imaging of BiPI-G0, BiPI-G1 and BiPI-G2
WT-DBT cells were seeded into 35 mm MatTek dishes (MatTek Corporation) and cultured for 24 h. Cells were treated with 5 μM BiPI-G0, BiPI-G1 and BiPI-G2 at 37 °C for 3 h in a water-jacketed incubator (37 °C, 5% CO 2 ). After being washed with PBS twice to remove residues of dendrimers, the cells were imaged using the Zeiss Axio Observer fluorescent microscope equipped with the ApoTome 2 imaging system. Rhodamine filter was used to image fluorescent probes (Excitation/Emission: 538-562/570-640 nm). Differential interference contrast (DIC) images were obtained through Trans light DIC.
Quantification of BiPI dendrimer uptake in cells
WT-DBT cells were incubated with 5 µM of BiPI-G0, BiPI-G1 or BiPI-G2 for 3 h. Cells were washed with PBS once. Fluorescence intensity of the dendrimers uptake in cells and those left in cell medium and PBS was measured respectively, using a SynergyTM H4 Hybrid Multi-Mode Microplate Reader. Specific excitation/emission wavelength that corresponds to the maximum absorption/emission of each BiPI dendrimer was used to measure fluorescence intensity as follows: 535/663 nm (BiPI-G0), 540/661 nm (BiPI-G1), and 545/646 nm (BiPI-G2).
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Supporting Information Figure S4 . Cellular uptake of dendrimers. Cells were incubated with 5 µM of BiPI-G0, BiPI-G1 and BiPI-G2 for 3 h. Fluorescence intensity of the uptaken (in cells) and unbound (in cell medium) molecules was measured respectively. Each data point represents the mean ± standard error of the mean (SEM) based on triplicate samples.
Concentration-dependent and incubation time-dependent cell uptake.
To measure concentration-dependent uptake, WT-DBT cells were treated with 0, 0.625, 1.25, 2.5, 5, or 10 µM of each BiPI dendrimer for 3 h. To measure incubation time-dependent uptake, cells were treated with 5 µM of each BiPI dendrimer for indicated time (0 min, 5 min, 30 min, 1 h, 3 h, 6 h, 24 h). Fluorescence intensity was measured after cells were washed with PBS once. Specific excitation/emission wavelength that corresponds to the maximum absorption/emission of each BiPI dendrimer was used to measure fluorescence intensity as follows: 535/663 nm (BiPI-G0), 540/661 nm (BiPI-G1), and 545/646 nm (BiPI-G2).
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